Summary The frequency of DNA aneuploidy was investigated by flow cytometry in 156 colorectal adenomas including 56 associated with 36 synchronous adenocarcinomas. Nine of 156 adenomas (6%) were DNA aneuploid. DNA aneuploidy correlated with increasing size (P<0.005) and histopathological type (P<0.05) but not with dysplasia. Adenomas in association with a synchronous adenocarcinoma did not have an increased incidence of DNA aneuploidy. Adenocarcinomas found in association with adenomas tend to have a lower incidence of DNA aneuploidy than the generality of colorectal cancers.
DNA aneuploidy as measured by flow cytometry is present in about 60% of colorectal adenocarcinomas (Tribukait et al., 1983; Armitage et al., 1985; Quirke et al., unpublished observations) . Early studies have suggested that aneuploidy is an important new independent prognostic variable unrelated to tumour grade or pathological stage (Wolley et al., 1982; Armitage et al., 1985) . Studies in premalignant conditions such as long standing ulcerative colitis (Hammarberg et al., 1984) , cervical intraepithelial neoplasia (Jakobsen et al., 1983) and giant melanocytic naevi (Stenzinger et al., 1984) have shown that DNA aneuploidy can arise prior to the onset of invasive malignancy and as such may be a sensitive early indicator of biological aggressiveness. Recently, and after commencement of our own work, Van den Ingh et al. (1985) and Weiss et al. (1985) have demonstrated aneuploidy in colorectal adenomas utilising fresh tissue. However, they did not explore the relationship to synchronous carcinoma.
The study reported here was undertaken to establish the frequency of DNA aneuploidy in a large series of colorectal adenomas and to relate this to the currently accepted criteria of likely malignant transformation: severe dysplasia, histological type and size of adenoma. We have also investigated whether or not there is a higher incidence of DNA aneuploidy in adenomas found in association with synchronous adenocarcinoma.
Materials and methods

Cases studied
One hundred and fifty-six colorectal adenomas including 56 (Ekelund & Lindstrom, 1974; Kozuka, 1975; and Konishi & Morson, 1982) . The maximum diameter of each tumour was measured from the slide (Konishi & Morson, 1982) in order to eliminate interobserver variation in the estimation of size taken from the original gross descriptions. The adenomas were grouped according to whether they were <lcm, 1-2cm, or >2cm in diameter. The colorectal carcinomas were graded into well, moderate or poor histological differentiation using accepted criteria (Grinnell, 1939) .
Flow cytometry
Nuclear DNA measurements were performed using a modification of the method of Hedley et al. (1983) . Fifty jim sections were cut from paraffin embedded material and transferred to glass slides. The sections were dewaxed in xylene and rehydrated by passing through a graded series of alcohols: 100%, 95%, 90%, 70% and 50% and washing twice in distilled water. The tissue was removed from the slide with a scalpel and placed in a test tube with 0.5% pepsin (Sigma Chemical Company, Pool BH17 7NH) in 0.9% NaCl adjusted to pH 1.5 with 2N HCI, and incubated at 37°C for 30min in a waterbath. After centrifugafugation at 2000 rpm, the pellet was washed twice in distilled water and stained by suspending in a solution ( jig ml-1) of 4'-6-diamidino-2-phenylindoledihydrochloride (Boehringer Mannheim, West Germany) in RPMI 1640 tissue culture medium at 20°C for 30min before filtering through four layers of butter muslin and syringing with a 23 gauge needle. Samples were analysed on an EPICS V flow (Q The Macmillan Press Ltd., 1986 cytometer (Coulter Electronics, Hialeh, Florida, USA). For excitation a Coherent Innova-90 5W UV enhanced argon ion laser was used at 50mW at a wavelength of 350nm.
A 408 nm interference filter removed scattered ultra-violet light. Ten thousand nuclei were counted. DNA aneuploidy was defined as the presence of more than one GO/Gl peak (Hiddemann et al., 1984) .
Internal standards were not included for reasons previously stated (Hedley et al., 1983 (Hedley et al., , 1985 . The DNA index was calculated for DNA aneuploid samples as being the ratio of the abnormal GO/G1 peak modal channel number to diploid GO/G1 peak modal channel number. A ,standard programme (Coulter Electronics, Hialeh, Florida, USA) was used to calculate the half peak coefficient of variation. The mean coefficient of variation was 7%.
Statistical analysis of the contingency tables was performed using the Chi squared test with a Yates correction where necessary.
Results
Pathology
The relationship between histological type, degree of dysplasia and size for isolated adenomas and those with synchronous carcinoma are shown in Table I . Adenomas found in association with adenocarcinomas differed in tending to be more commonly smaller in size and of tubular type.
Eight of thirty-six adenocarcinomas (22%) were graded as well differentiated, 17/36 (47%) moderately well differentiated and 11/36 (31%) poorly differentiated. There was no significant correlation between histological grade of adenocarcinoma and grade of dysplasia (P=0.74), size (P= 0.09) or type (P= 0.46) of synchronous adenoma.
Flow cytometry Of the 156 adenomas 9 (6%) were found to be DNA aneuploid (see Figure 1) . DNA aneuploidy was significantly associated with the size and type of adenoma but not with the degree of dysplasia (see Table II ). Size of adenoma was the most significant factor with DNA aneuploidy being present in none of <1.0cm, 4 (7%) of 1.0-2.0cm and 5 (16%) of >2.0cm (P<0.005). Tubular adenomas demonstrated the lowest incidence (2%) with higher levels found in tubulo-villous (13%) and villous adenomas (11%) (P<0.04).
Of the 36 adenocarcinomas, 12 (33%) were found to be DNA aneuploid. No relationship was found between histological grade and DNA aneuploidy or the incidence of DNA aneuploidy in adenomas associated with (4%) or without (7%) synchronous adenocarcinoma. Of the two DNA aneuploid (Brown et al., 1985) . Other factors suggested to be of value in assessessing progression in the adenoma-carcinoma sequence include ultrastructural changes (Kaye et al., 1971; Fenoglio et al., 1975) , cell kinetic and pericryptal fibroblast changes (Kaye et al., 1971) , differences in mucin (Filipe & Branfoot, 1976; Culling et al., 1977) and lectin profiles (Boland et al., 1982) , immunohistochemistry (Rognum et al., 1982) and the appearance of foetal blood group antigens (Cooper et al., 1980) . However, none of these have yet proved of value in predicting the invasive potential of adenomas.
Measurement of DNA aneuploidy by flow cytometry is quantitative and reproducible. Evidence is now accumulating that it is a marker of poor prognosis in colorectal adenocarcinoma (Wolley et al., 1982; Armitage et al., 1985) as well as in tumours of ovary (Friedlander et al., 1984a) , breast (Friedlander et al., 1984b) and cervix (Jakobsen et al., 1984) . The demonstration of such karyotypic progression in a small percentage of adenomas as compared to the much higher level seen in adenocarcinomas suggests it may be a useful early marker of biological aggressiveness. Support for this conclusion can be derived from similar findings in previous studies on the chromosomal constitution of adenomas and adenocarcinomas (Enterline & Arvan, 1967; Reichmann et al., 1981) and the strong association between DNA aneuploidy and size of adenoma and to a lesser extent histopathological type. The highly significant association between size and DNA aneuploidy is important as size has been shown to be an excellent predictor of the presence of carcinomatous change in an adenoma (Muto et al., 1975) . Size is followed by histopathological type and lastly the degree of dysplasia in predictive ability.
Our findings are supported by those of van den Ingh et al. (1985) who in a smaller series of 55 colorectal adenomas reported a significant association between DNA aneuploidy and tumour size. They did not however find any significant association between the histopathological type of adenoma or the degree of dysplasia and DNA aneuploidy. These workers also found a substantially higher percentage of DNA aneuploidy (27% vs. 6%) than observed in this study. There are three possible explanations for this discrepancy. Firstly, they used fresh tissue in association with a biological internal standard and defined DNA aneuploidy in two ways: either when there were two or more GO/G1 peaks (as used in this study) or when the GO/G1: internal standard ratio was either increased or decreased above threshold levels. This second definition has been severely criticised in a study of lymphomas (Shackney et al., 1984) and has not been adopted in a recent international report on nomenclature in DNA cytometry (Hiddemann et al., 1984) . Secondly, the observed incidence of DNA aneuploidy is dependent upon the technique of DNA staining employed and the sensitivity of the flow cytometric measurements. The latter is expressed by the coefficient of variation (CV) of the GO/GI peak, the incidence of DNA aneuploidy tending to increase with a decreasing CV. In order to make meaningful comparisons of flow cytometric data, CVs should be stated (Hiddemann et al., 1984) . In our experience higher coefficients of variation are given by archival paraffin embedded material than fresh tissue and this may lead to a loss of resolution of peridiploid peaks, but this does not outweigh the usefulness of the technique (Hedley et al., 1985) . Thirdly, only 15% of their adenomas were <1 cm in size as compared to a more representative 45% in this series. Weiss et al. (1985) reported DNA aneuploidy in 9% of their 58 non-malignant adenomas. The histological assessments in this study are open to criticism for three reasons. Firstly, 30 of the 64 adenomas were designated to be non-dysplastic, a contradiction in terms, as all adenomas show at least mild dysplastic change (Morson & Dawson, 1979) . Secondly, they failed to recognise any pure villous adenomas and finally they did not measure the size of the adenomas, the most important factor in assessing malignant potential (Muto et al., 1975) .
The relatively low incidence of DNA aneuploidy found in adenomas when compared to carcinomas probably reflects the long natural history of the adenoma-carcinoma sequence which is considered to take on average 10-15 years (Morson, 1974) . It is also of interest that comparison of isolated versus cancer-associated adenomas, revealed no increase in incidence of DNA aneuploidy in adenomas associated with adenocarcinomas, and DNA aneuploid adenocarcinomas were not found to be associated with DNA aneuploid adenomas. It is noteworthy also that the percentage of DNA aneuploid adenocarcinomas in this study was low (11/36:33%) as compared to the rate of 60% found in over 160 colorectal adenocarcinomas measured under exactly the same conditions in parallel studies (Quirke et al., unpublished observations) . Although the numbers of synchronous adenocarcinomas measured are small the increased incidence of diploid carcinomas (67% vs. 40%) may reflect an intrinsically longer natural history in such tumours, allowing more time for adenomas to develop synchronously within the surrounding colon.
It can be concluded that the use of DNA measurements in colorectal adenomas allows identification of more biologically aggressive tumours and indicates a group of patients who require closer surveillance. However, the demonstration of aneuploidy of itself will not identify all patients at risk from the adenoma-carcinoma sequence since a substantial proportion of colorectal adenocarcinomas are diploid (Rognum et al., 1982; Tribukait et al., 1983; Quirke et al., -1985; Armitage et al., 1985) and remain so throughout their natural history (Rognum et al., 1985; Quirke et al., unpublished observations) . To identify such cases other techniques will require evaluation including cell cycle analysis or a combination of flow cytometric DNA measurements with antibodies to oncogene products or cell surface receptors, or fluorescent oncogene probes.
